0

IN THIS ISSUE

JAMA: The Journal of the American Medical Association

July 14, 2004, Vol 292, No. 2
Theme: HIV/AIDS
Basic View  |  Expanded View
Baby MoBaby Mo
Topics:
JAMA. 2004;292(2):153-154.  doi: 10.1001/jama.292.2.153
Efficacy of an HIV Prevention Intervention for African American Adolescent Girls: Title and subTitle BreakA Randomized Controlled Trial FREE
Ralph J. DiClemente, PhD; Gina M. Wingood, ScD, MPH; Kathy F. Harrington, MPH, MAEd; Delia L. Lang, PhD, MPH; Susan L. Davies, PhD, MEd; Edward W. Hook III, MD; M. Kim Oh, MD; Richard A. Crosby, PhD; Vicki Stover Hertzberg, PhD; Angelita B. Gordon, MS; James W. Hardin, PhD; Shan Parker, PhD, MPH; Alyssa Robillard, PhD, MSPH
Topics: hiv, sex behavior, sexually transmitted diseases, african american, hiv prevention
JAMA. 2004;292(2):171-179.  doi: 10.1001/jama.292.2.171
Efficacy and Safety of Emtricitabine vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: Title and subTitle BreakA Randomized Trial FREE
Michael S. Saag, MD; Pedro Cahn, MD; François Raffi, MD; Marcelo Wolff, MD; Daniel Pearce, DO; Jean-Michel Molina, MD; William Powderly, MD; Audrey L. Shaw, PhD; Elsa Mondou, MD; John Hinkle, PhD; Katyna Borroto-Esoda, MS; Joseph B. Quinn, MSPH; David W. Barry, MD; Franck Rousseau, MD; for the FTC-301A Study Team
Topics: efavirenz, combined modality therapy, safety, stavudine, viral load result, emtricitabine, anti-retroviral agents, adverse event
JAMA. 2004;292(2):180-189.  doi: 10.1001/jama.292.2.180
Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: Title and subTitle BreakA 3-Year Randomized Trial FREE
Joel E. Gallant, MD, MPH; Schlomo Staszewski, MD; Anton L. Pozniak, MD; Edwin DeJesus, MD; Jamal M. A. H. Suleiman, MD; Michael D. Miller, PhD; Dion F. Coakley, PharmD; Biao Lu, PhD; John J. Toole, MD, PhD; Andrew K. Cheng, MD, PhD; for the 903 Study Group
Topics: efavirenz, combined modality therapy, safety, stavudine, tenofovir, blood hiv rna, anti-retroviral agents
JAMA. 2004;292(2):191-201.  doi: 10.1001/jama.292.2.191
Nevirapine and Zidovudine at Birth to Reduce Perinatal Transmission of HIV in an African Setting: Title and subTitle BreakA Randomized Controlled Trial FREE
Taha E. Taha, MBBS, PhD; Newton I. Kumwenda, PhD; Donald R. Hoover, PhD; Susan A. Fiscus, PhD; George Kafulafula, MBBS, FCOG; Chiwawa Nkhoma, MSc; Samah Nour, MBBCh; Shu Chen, MSc; George Liomba, MBBS, FRCPath; Paolo G. Miotti, MD; Robin L. Broadhead, MBBS, FRCP
Topics: nevirapine, zidovudine, perinatal period, birth, hiv transmission
JAMA. 2004;292(2):202-209.  doi: 10.1001/jama.292.2.202
Growth Hormone–Releasing Hormone in HIV-Infected Men With Lipodystrophy: Title and subTitle BreakA Randomized Controlled Trial FREE
Polyxeni Koutkia, MD, MA; Bridget Canavan, BA; Jeff Breu, BS; Martin Torriani, MD; John Kissko, MS; Steven Grinspoon, MD
Topics: hiv, lipodystrophy, growth hormone-releasing factor, sermorelin
JAMA. 2004;292(2):210-218.  doi: 10.1001/jama.292.2.210
Rapid HIV-1 Testing During Labor: Title and subTitle BreakA Multicenter Study FREE
Marc Bulterys, MD, PhD; Denise J. Jamieson, MD, MPH; Mary Jo O'Sullivan, MD; Mardge H. Cohen, MD; Robert Maupin, MD; Steven Nesheim, MD; Mayris P. Webber, DrPH; Russell Van Dyke, MD; Jeffrey Wiener; Bernard M. Branson, MD; for the Mother-Infant Rapid Intervention At Delivery (MIRIAD) Study Group
Topics: hiv, antiretroviral therapy, highly active, hiv-1, labor, rapid hiv test, rapid screening test
JAMA. 2004;292(2):219-223.  doi: 10.1001/jama.292.2.219
Highly Active Antiretroviral Therapy and Sexual Risk Behavior: Title and subTitle BreakA Meta-analytic Review FREE
Nicole Crepaz, PhD; Trevor A. Hart, PhD; Gary Marks, PhD
Topics: antiretroviral therapy, highly active, viral load result
JAMA. 2004;292(2):224-236.  doi: 10.1001/jama.292.2.224
Clinical Trials in Sub-Saharan Africa and Established Standards of Care: Title and subTitle BreakA Systematic Review of HIV, Tuberculosis, and Malaria Trials FREE
David M. Kent, MD, MS; D. Mkaya Mwamburi, MD, MS; Michael L. Bennish, MD; Bruce Kupelnick, BA; John P. A. Ioannidis, MD
Topics: hiv, africa south of the sahara, malaria, tuberculosis, tuberculosis and hiv, standard of care
JAMA. 2004;292(2):237-242.  doi: 10.1001/jama.292.2.237
Clinician's Corner
Treatment for Adult HIV Infection: Title and subTitle Break2004 Recommendations of the International AIDS Society-USA Panel
Patrick G. Yeni, MD; Scott M. Hammer, MD; Martin S. Hirsch, MD; Michael S. Saag, MD; Mauro Schechter, MD, PhD; Charles C. J. Carpenter, MD; Margaret A. Fischl, MD; Jose M. Gatell, MD, PhD; Brian G. Gazzard, MA, MD; Donna M. Jacobsen, BS; David A. Katzenstein, MD; Julio S. G. Montaner, MD; Douglas D. Richman, MD; Robert T. Schooley, MD; Melanie A. Thompson, MD; Stefano Vella, MD; Paul A. Volberding, MD
Includes: CME
Topics: hiv, acquired immunodeficiency syndrome, abacavir, didanosine, efavirenz, cd4 count determination procedure, lamivudine, nelfinavir, nevirapine, plasma, protease inhibitor, ritonavir, stavudine, zidovudine, tenofovir, lopinavir, blood hiv rna, atazanavir, hiv infection, toxic effect, anti-retroviral agents, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors
JAMA. 2004;292(2):251-265.  doi: 10.1001/jama.292.2.251
HIV Infection, Hepatitis C Infection, and HAART: Title and subTitle BreakHard Clinical Choices
Shyam Kottilil, MD, PhD; Michael A. Polis, MD, MPH; Joseph A. Kovacs, MD
Topics: hiv, antiretroviral therapy, highly active, hepatitis c, infection, hiv infection, hepatotoxicity, hepatitis c virus, anti-retroviral agents
JAMA. 2004;292(2):243-250.  doi: 10.1001/jama.292.2.243
Treatment of HIV/AIDS: Title and subTitle BreakDo the Dilemmas Only Increase?
Merle A. Sande, MD; Allan Ronald, MD
Topics: hiv
JAMA. 2004;292(2):266-268.  doi: 10.1001/jama.292.2.266
The Long Journey to Health Equity
Timothy F. Brewer, MD, MPH; S. Jody Heymann, MD, PhD
Topics: hiv, ethics, africa, africa south of the sahara, insecticides, malaria, mothers, tuberculosis, vaccination, vaccines, world health organization, infection, hepatitis b virus measurement, morbidity, mortality, hiv infection, anti-retroviral agents, hiv transmission, health maintenance/preventive medicine
JAMA. 2004;292(2):269-271.  doi: 10.1001/jama.292.2.269
Strategies to Diagnose and Treat Group A Streptococcal Pharyngitis—ReplyStrategies to Diagnose and Treat Group A Streptococcal Pharyngitis—Reply
Topics:
JAMA. 2004;292(2):167-167.  doi: 10.1001/jama.292.2.167-b
Strategies to Diagnose and Treat Group A Streptococcal PharyngitisStrategies to Diagnose and Treat Group A Streptococcal Pharyngitis
Topics:
JAMA. 2004;292(2):167-167.  doi: 10.1001/jama.292.2.167-a
Pharmacological Treatment of Delirium in the Intensive Care UnitPharmacological Treatment of Delirium in the Intensive Care Unit
Topics:
JAMA. 2004;292(2):168-168.  doi: 10.1001/jama.292.2.168-a
Pharmacological Treatment of Delirium in the Intensive Care Unit—ReplyPharmacological Treatment of Delirium in the Intensive Care Unit—Reply
Topics:
JAMA. 2004;292(2):168-168.  doi: 10.1001/jama.292.2.168-b
On-Pump vs Off-Pump Coronary Artery Bypass GraftingOn-Pump vs Off-Pump Coronary Artery Bypass Grafting
Topics:
JAMA. 2004;292(2):169-169.  doi: 10.1001/jama.292.2.169-c
On-Pump vs Off-Pump Coronary Artery Bypass Grafting—ReplyOn-Pump vs Off-Pump Coronary Artery Bypass Grafting—Reply
Topics:
JAMA. 2004;292(2):169-169.  doi: 10.1001/jama.292.2.169-d
Risk-Treatment Paradox in Use of Statins—ReplyRisk-Treatment Paradox in Use of Statins—Reply
Topics:
JAMA. 2004;292(2):169-169.  doi: 10.1001/jama.292.2.169-b
Risk-Treatment Paradox in Use of StatinsRisk-Treatment Paradox in Use of Statins
Topics:
JAMA. 2004;292(2):169-169.  doi: 10.1001/jama.292.2.169-a
Fee-for-Service vs Managed Care MedicineFee-for-Service vs Managed Care Medicine
Topics:
JAMA. 2004;292(2):170-170.  doi: 10.1001/jama.292.2.170-a
Fee-for-Service vs Managed Care Medicine—ReplyFee-for-Service vs Managed Care Medicine—Reply
Topics:
JAMA. 2004;292(2):170-170.  doi: 10.1001/jama.292.2.170-b
Nonfatal and Fatal Drownings in Recreational Water Settings—United States, 2001-2002 FREE
Topics: drowning
JAMA. 2004;292(2):164-166.  doi: 10.1001/jama.292.2.164
Availability of Diphtheria Antitoxin Through an Investigational New Drug Protocol FREE
Topics: diphtheria antitoxin, investigational new drugs
JAMA. 2004;292(2):166-166.  doi: 10.1001/jama.292.2.166
FDA Tobacco Regulation
Topics: tobacco, united states food and drug administration
JAMA. 2004;292(2):163-163.  doi: 10.1001/jama.292.2.163-b
Plan B Reversal?
Topics: levonorgestrel
JAMA. 2004;292(2):163-163.  doi: 10.1001/jama.292.2.163-d
Slow Card Uptake
Topics: elderly
JAMA. 2004;292(2):163-163.  doi: 10.1001/jama.292.2.163-a
Stem Cell Pressure
Topics: stem cells, hematopoietic stem cells
JAMA. 2004;292(2):163-163.  doi: 10.1001/jama.292.2.163-c
A Cover Without ArtA Cover Without Art
Topics:
JAMA. 2004;292(2):150-150.  doi: 10.1001/jama.292.2.150
Afferent ReceptorsAfferent Receptors
Topics:
JAMA. 2004;292(2):152-152.  doi: 10.1001/jama.292.2.152
HOW THE GENERAL PRACTITIONER SHOULD TREAT GONORRHEA.HOW THE GENERAL PRACTITIONER SHOULD TREAT GONORRHEA.
Topics:
JAMA. 2004;292(2):281-281.  doi: 10.1001/jama.292.2.281
Conquering HIV and Stigma in Kenya
Topics: hiv, kenya, social stigma
JAMA. 2004;292(2):157-159.  doi: 10.1001/jama.292.2.157
Small Loans Yield Big Health Profits
Topics: hiv, acquired immunodeficiency syndrome, malawi, microbiology procedure
JAMA. 2004;292(2):159-160.  doi: 10.1001/jama.292.2.159
Thousands Fall Through HIV Treatment Gap
Topics: hiv
JAMA. 2004;292(2):161-162.  doi: 10.1001/jama.292.2.161
Report: HIV Prevention Efforts Remain Crucial as Global Treatment Access Expands
Topics: hiv prevention
JAMA. 2004;292(2):162-162.  doi: 10.1001/jama.292.2.162
Topics:
JAMA. 2004;292(2):.  doi: 10.1001/jama.292.2.278
AIDS, SocietyAIDS, Society
Topics:
JAMA. 2004;292(2):.  doi: 10.1001/jama.292.2.276
HIV, AfricaHIV, Africa
Topics:
JAMA. 2004;292(2):.  doi: 10.1001/jama.292.2.275
HIV, DisclosureHIV, Disclosure
Topics:
JAMA. 2004;292(2):.  doi: 10.1001/jama.292.2.277
HIV Infection: The Basics FREE
Lise M. Stevens, MA; Cassio Lynm, MA; Richard M. Glass, MD
Topics: hiv, hiv infection
JAMA. 2004;292(2):296-296.  doi: 10.1001/jama.292.2.296

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems